Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Am J Respir Cell Mol Biol ; 16(4): 372-8, 1997 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9115747

RESUMO

The role of protein tyrosine kinases (PTK) in modulating contractility has not been investigated in airway smooth muscle (ASM). We have examined the effects of the PTK inhibitors ST638, genistein, and tyrphostin A47 on contractions induced by carbachol, serotonin, ionomycin, and 75 mM KCl in isolated bronchioles of the rat with internal diameters of 614 +/- 16 microm (small, n = 143), and 1,433 +/- 39 microm (large, n = 57). ST638 caused a dose-dependent decrease in the maximum response to carbachol, and shifted the carbachol concentration-response curve to the right. This effect was greater in small bronchioles. Tyrphostin A47 (100 microM) and genistein (74 microM) had a similar effect to ST638. ST638 caused a concentration-dependent relaxation (EC50 approximately 7.2 microM) in bronchioles precontracted with 0.5 microM carbachol, and was maximally effective at 50 microM when tone was reduced by 82.5 +/- 3.8% in small bronchioles, and 57.2 +/- 2.8% in large bronchioles. ST638 also reduced the maximal response to serotonin, and caused a large shift to the right of the serotonin concentration-response curve. Pretreatment with ST638 (50 microM) reduced the response to 75 mM KCl in both small and large bronchioles in the presence of atropine (small: by 88.9 +/- 5.6%, n = 11; large: by 90.1 +/- 4.4%, n = 11). Tyrphostin A47 (100 microM) had a similar effect (91%). ST638 (50 microM) and tyrphostin A47 (100 microM) substantially relaxed small bronchioles contracted with 1.5 microM ionomycin (ST638: by 86.7 +/- 1.8%, n = 6; tyrphostin: by 89.3 +/- 1.7%, n = 5). We have therefore demonstrated that PTK inhibitors can suppress contraction induced by a number of different mechanisms in ASM. These results suggest that PTK signaling pathways are not only important for proliferation of ASM, but also fon contractile function.


Assuntos
Brônquios/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Proteínas Tirosina Quinases/antagonistas & inibidores , Tirfostinas , Acetilcolina/metabolismo , Animais , Brônquios/metabolismo , Brônquios/fisiologia , Ácidos Cafeicos/farmacologia , Carbacol/farmacologia , Cinamatos/farmacologia , Fator de Crescimento Epidérmico/farmacologia , Genisteína , Técnicas In Vitro , Indóis/farmacologia , Ionomicina/farmacologia , Isoflavonas/farmacologia , Masculino , Contração Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Músculo Liso/metabolismo , Músculo Liso/fisiologia , Ratos , Ratos Wistar , Serotonina/farmacologia , Sulfetos/farmacologia
2.
Clin Nucl Med ; 21(11): 834-7, 1996 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8922842

RESUMO

A case of Meckel's diverticulum causing intussusception in an 8-year-old boy is presented. The Meckel's diverticulum was detected by using a Tc-99m-labeled antigranulocyte monoclonal antibody MN3 (Leukoscan; Immunomedics, Morris Plains, NJ), which is under clinical evaluation for the detection of atypical appendicitis at the authors' institution. Pathologic evaluation confirmed Meckel's diverticulitis with ileal-ileal intussusception.


Assuntos
Anticorpos Monoclonais , Doenças do Íleo/diagnóstico por imagem , Intussuscepção/diagnóstico por imagem , Divertículo Ileal/complicações , Tecnécio , Anticorpos Monoclonais Murinos , Apendicite/diagnóstico , Criança , Diagnóstico Diferencial , Humanos , Doenças do Íleo/etiologia , Intussuscepção/etiologia , Masculino , Cintilografia
3.
Br J Pharmacol ; 113(4): 1237-42, 1994 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7889278

RESUMO

1. The involvement of protein kinase C (PKC) in constriction of small bronchioles has never been investigated. In this study we have examined the effects of the specific PKC inhibitors Ro31-8220 and Ro31-7549 and the non-specific inhibitor H7 on carbachol-, 5-hydroxytryptamine (5-HT)- and 4 beta-phorbol dibutyrate (4 beta-PDBu)-induced contractions in large and small bronchioles. 2. The study was performed on isolated bronchioles of the rat with internal diameters of 574 microns +/- 11 (small, n = 128), and 1475 microns +/- 32 (large, n = 93), using a Mulvaney-Halpen small vessel myograph. 3. In these preparations 4 beta-PDBu had no effect if added on its own. However, after precontracting with 30 mM K+, 0.5 microM 4 beta-PDBu caused a contractile response of 110.4 +/- 7.0% TK (TK = maximum response to 75 mM K+ in small and 69.3 +/- 6.5% TK in large bronchioles. Ro31-8220, Ro31-7549 and H7 all showed concentration-dependent inhibition of this response. 4. In small bronchioles 10 microM Ro31-8220 shifted both the carbachol and 5-HT concentration-response curves to the right, and reduced the maximum response. In contrast, 10 microM Ro31-8220 had no significant effect on the EC50 to carbachol of larger bronchioles, although the maximum response was reduced, and had no significant effect on the 5-HT concentration-response curve. 200 microM H7 shifted the carbachol concentration--response curve to the right as well as reducing the maximal response in both small and large bronchioles. 5 Large bronchioles exhibited a greater rate of decay of carbachol-induced contraction than did small bronchioles. Pretreatment with Ro31-8220 accelerated the rate of decay.6 Pretreatment with 10 JM Ro3l-8220 caused a small reduction in the response to 75 mM K+ in both small and large bronchioles (small: to 87.8 +/- 3.0% TK; large: to 94.1 +/- 0.8% TK). H7 at 200 JM caused a much larger reduction in both preparations (small: to 75.1 +/- 3.0% TK); large: to 82.7 +/- 0.6% TK).7 Small bronchioles were more sensitive than larger bronchioles to agonists and phorbol ester. The protein kinase inhibitor Ro31-8220 could reduce agonist-induced constriction in small and large bronchioles,as well as reducing or abolishing phorbol ester-induced contractions. Small bronchioles were more sensitive than large bronchioles to Ro31-8220. These results suggest that there is a significant PKC involvement in constriction of bronchioles to carbachol and 5-HT, and that the proportion of the contractile response that can be attributed to PKC is greater in smaller than larger bronchioles.


Assuntos
Brônquios/efeitos dos fármacos , Indóis/farmacologia , Músculo Liso/efeitos dos fármacos , Proteína Quinase C/antagonistas & inibidores , 1-(5-Isoquinolinasulfonil)-2-Metilpiperazina , Animais , Brônquios/anatomia & histologia , Brônquios/enzimologia , Broncoconstrição/efeitos dos fármacos , Carbacol/antagonistas & inibidores , Carbacol/farmacologia , Técnicas In Vitro , Isoquinolinas/farmacologia , Masculino , Maleimidas/farmacologia , Músculo Liso/anatomia & histologia , Músculo Liso/enzimologia , Dibutirato de 12,13-Forbol/farmacologia , Piperazinas/farmacologia , Ratos , Ratos Wistar , Serotonina/farmacologia
4.
Br J Pharmacol ; 105(2): 259-60, 1992 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-1559123

RESUMO

The effects of BRL 38227 and glibenclamide on intracellular calcium stores were investigated in permeabilized cultured airway smooth muscle cells of the rabbit using 45Ca effluxes. BRL 38227 (10 microM) reduced loading of the inositol 1,4,5-trisphosphate (InsP3)-sensitive intracellular store by 26.5% +/- 1.0; this effect was antagonized by 1 microM glibenclamide. BRL 38227 itself did not release calcium and had no effect on guanosine 5'-0-(3-thiotriphosphate)-induced calcium release. Glibenclamide (greater than or equal to 5 microM) also reduced calcium loading of the intracellular store, and enhanced calcium release. These results suggest that BRL 38227 has a direct effect on intracellular calcium handling.


Assuntos
Benzopiranos/farmacologia , Cálcio/metabolismo , Glibureto/farmacologia , Músculo Liso/metabolismo , Pirróis/farmacologia , Traqueia/metabolismo , Animais , Linhagem Celular , Células Cultivadas , Cromakalim , Músculo Liso/efeitos dos fármacos , Coelhos , Retículo Sarcoplasmático/efeitos dos fármacos , Traqueia/efeitos dos fármacos
5.
Br J Pharmacol ; 104(4): 901-6, 1991 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-1810602

RESUMO

1. The interaction between inositol 1,4,5-trisphosphate (InsP3) and guanosine 5'-O-(3-thio triphosphate) (GTP gamma S) releasable calcium (Ca2+) pools was examined using 45Ca effluxes in permeabilized cultured airway smooth muscle cells from rabbit trachea. 2. Addition of InsP3 or GTP gamma S caused a concentration-dependent release of intracellular Ca2+. The release of Ca2+ by InsP3 was much greater than with GTP gamma S. Pretreatment with maximally effective InsP3 (10 microM) abolished the GTP gamma S-induced Ca2+ release, whereas pretreatment with 100 microM GTP gamma S reduced the InsP3-induced Ca2+ release by 25%. 3. Ryanodine (100 microM), also gave a large release of intracellular Ca2+. After pretreatment with 100 microM ryanodine, GTP gamma S did not induce Ca2+ release, and InsP3-induced Ca2+ release was reduced by 76%. 4. Caffeine (50 mM), produced a slow release of intracellular Ca2+. Pre-exposure to 50 mM caffeine had no effect on the GTP gamma S-induced Ca2+ release but reduced the InsP3 releasable Ca2+ by 58%. 5. Pretreatment with ryanodine abolished the caffeine-induced Ca2+ release, and addition of caffeine before ryanodine reduced the ryanodine-induced Ca2+ release by 64.4%. 6. These results suggest that there are at least three pools of Ca2+ present within airway smooth muscle cells. The largest pool is released by InsP3 or ryanodine, another is released either by a high concentration of InsP3 or on application of GTP gamma S, and the third by InsP3 alone. Ca2+ may be able to move from the GTP gamma S-sensitive pool into the InsP3- and ryanodine-sensitive pool when this becomes depleted. In contrast, the opposite movement of Ca2 + cannot occur.


Assuntos
Cálcio/metabolismo , Guanosina 5'-O-(3-Tiotrifosfato)/farmacologia , Inosina Trifosfato/farmacologia , Músculo Liso/metabolismo , Animais , Cafeína/farmacologia , Radioisótopos de Cálcio , Células Cultivadas , Masculino , Músculo Liso/efeitos dos fármacos , Coelhos , Rianodina/farmacologia , Retículo Sarcoplasmático/efeitos dos fármacos , Retículo Sarcoplasmático/metabolismo , Traqueia/citologia , Traqueia/efeitos dos fármacos , Traqueia/metabolismo
6.
Biochem Biophys Res Commun ; 163(1): 262-8, 1989 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-2673237

RESUMO

The effects of heparin on intracellular calcium release in monolayers of permeabilised cultured rabbit smooth muscle cells were determined using 45Ca effluxes. Low molecular weight heparin inhibited inositol 1,4,5-trisphosphate (InsP3) induced Ca2+ release (IC50 = 0.8 microgram/ml), but not guanosine 5'-O-(3-thio triphosphate) (GTP gamma S) stimulated Ca2+ release. Only a small inhibition was noted with high molecular weight heparin and de-N-sulphated heparin, although chondroitin sulphate A potently inhibited the InsP3 response. These results indicate the competitive and specific nature of the heparin effect and give information about the structure of the InsP3 site.


Assuntos
Cálcio/metabolismo , Guanosina Trifosfato/análogos & derivados , Heparina/farmacologia , Fosfatos de Inositol/farmacologia , Músculo Liso/metabolismo , Fosfatos Açúcares/farmacologia , Tionucleotídeos/farmacologia , Animais , Relação Dose-Resposta a Droga , Guanosina 5'-O-(3-Tiotrifosfato) , Guanosina Trifosfato/farmacologia , Técnicas In Vitro , Inositol 1,4,5-Trifosfato , Fosfatos de Inositol/antagonistas & inibidores , Peso Molecular , Músculo Liso/efeitos dos fármacos , Coelhos , Relação Estrutura-Atividade , Traqueia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA